Mubadala, British Patient Capital back SV Health growth biotech fundraise
Abu Dhabi sovereign investment giant Mubadala has teamed with British Patient Capital to back SV Health Investors' Biotech Crossover Opportunities Fund. The post Mubadala, British Patient Capital back SV Health growth biotech fundraise first appeared